Navigation Links
BIOTEC researcher is one of the 'Highly Cited Researchers 2014'
Date:7/18/2014

The ranking list Highly Cited Researchers 2014" by Thomson Reuters named Dr. Michael Kuhn of the Biotechnology Center at the TU Dresden (BIOTEC) as one of the worldwide most cited researchers in the area biology and biochemistry. The American media company has evaluated the citation of scientific publications from 2002 until 2012 and listed 3,215 distinguished researchers in 21 different research areas in total.

Together with colleagues from Switzerland, Denmark and Germany, the computational biologist Michael Kuhn has designed and programmed a data base for proteins. This data base contains more than five million proteins including all 20,000 human proteins and others from different species. Proteins provide cells with structure and act as "molecular motors": They recognize messenger substances, transport metabolites and initiate chemical reactions. For example, p53 is one of the proteins with the most connections and prevents the development of cancer in healthy cells. When it is damaged, cells can develop into cancer cells. P53 is found in Kuhn's data base so that information about its interactions with other proteins and how they act together is accessible worldwide. Other researchers take advantage of this knowledge and refer to Kuhn's studies in the description of their research. The company Thomson Reuters tracks these references worldwide and has generated a list with the most cited researchers this year.

"During my PhD thesis at the European Molecular Biology Laboratory (EMBL) in Heidelberg, I have started this research and published about my work in scientific journals. We also used the data base ourselves, in order to gain new knowledge about the mechanisms of drug action from their side effects", says Michael Kuhn.

At the BIOTEC, the 32-year-old Kuhn, who is part of Professor Michael Schroeder's group, works on a project with the title "Tracing the molecular evolution of the centrosome: adaptation of components and function" which is funded by the German Research Foundation (DFG). The centrosome is located near the cell nucleus, and helps to provide new cells with the right size and components after cell division. The centrosome of animals is more complex than in unicellular organisms. In cooperation with Professor Anthony Hyman of the Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG), Kuhn explores which evolutionary mechanisms caused the centrosome's change in structure and function on the molecular level.

The complete list of the Highly Cited Researchers 2014" can be found on the Thomson Reuters website: http://highlycited.com


'/>"/>

Contact: Birte Urban-Eicheler
birte.urban-eicheler@crt-dresden.de
49-351-458-82065
Technische Universitt Dresden
Source:Eurekalert  

Related biology news :

1. NYU School of Medicine presents 2012 Dart/NYU Biotechnology Achievement Awards
2. Ben-Gurion U. licenses drug delivery platform for central nervous system diseases to NY biotech firm
3. New Biotech and Pharmaceutical Market Research from Global Information Inc Forecasts Strong Growth Coming Out of Recession
4. Genomatix wins the INDUSTRIEPREIS 2012 in the biotech category at Hannover Messe
5. How will the US biotechnology industry benefit from new patent laws?
6. 2012 AAPS National Biotechnology Conference heads to San Diego
7. AAPS National Biotechnology Conference to highlight innovative vaccines
8. Early Bird Discounts Available on International Healthcare and Biotechnology Conferences, Save Up To $600 with Global Information
9. Early Bird Offers on Healthcare and Biotechnology Conferences, Save Up To 20% by Registering with Global Information
10. Bigger refuges needed to delay pest resistance to biotech corn
11. Genetic Engineering & Biotechnology News unveils Biotech Boulevard
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
BIOTEC researcher is one of the 'Highly Cited Researchers 2014'
(Date:1/21/2017)... , Jan 20, 2017 Research and ... Biometrics Market 2017-2021" report to their offering. ... The global voice recognition biometrics ... 2017-2021. The report covers the present scenario and ... 2017-2021. To calculate the market size, the report considers the revenue ...
(Date:1/18/2017)...  In vitro diagnostic (IVD) companies were very active ... and Kalorama Information expects that trend to continue – ... Generally, uncertainty in reimbursement and healthcare reform in ... the acquisitions landscape. Instead of looking to buy technology, ... outside of their home country and also to increase ...
(Date:1/12/2017)...  Trovagene, Inc. (NASDAQ: TROV ), a ... that it has signed agreements with seven strategic partners ... Middle East for commercialization of the ... wave of international distribution agreements for Trovagene,s CLIA based ... The initial partners will introduce Trovagene,s liquid biopsy ...
Breaking Biology News(10 mins):
(Date:2/17/2017)... , Feb. 17, 2017  Protagonist Therapeutics, ... data on its oral peptide drug candidates, PTG-100 ... of the European Crohn,s and Colitis Organization (ECCO).  ... Barcelona, Spain from February 15 ... detail preclinical data on Protagonist drug candidates PTG-100 ...
(Date:2/16/2017)... Arbor, MI (PRWEB) , ... February 16, 2017 , ... ... 5:00-7:00 p.m. The event will be held at Avomeen Analytical Services (4840 Venture ... by a MichBio member organization. They provide an opportunity to interact with peers, make ...
(Date:2/16/2017)... and GREENWICH, Conn. ... private investment firm focused on venture growth investments ... promotion of Josh Richardson , M.D. to ... investments in biotechnology companies.  He is a board ... important roles in Longitude,s investments in Aimmune Therapeutics, ...
(Date:2/16/2017)... 2017  ArmaGen, Inc., a privately held biotechnology ... severe neurological disorders, today reported preliminary evidence of ... company,s investigational therapy for the treatment of Hurler ... I, or MPS I). The initial results from ... today at the 13 th annual WORLD ...
Breaking Biology Technology: